SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-070467
Filing Date
2021-05-21
Accepted
2021-05-21 16:05:21
Documents
2
Group Members
PONTIFAX (CAYMAN) III, L.P.PONTIFAX (CAYMAN) IV L.P.PONTIFAX (CHINA) IV L.P.PONTIFAX (ISRAEL) III, L.P.PONTIFAX (ISRAEL) IV L.P.PONTIFAX IV GP L.P.PONTIFAX LATE STAGE FUND L.P.PONTIFAX LATE STAGE GP LTD.PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.PONTIFAX MANAG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2117123d1_sc13da.htm SC 13D/A 229140
2 EXHIBIT 3 tm2117123d1_ex-3.htm EX-3 11423
  Complete submission text file 0001104659-21-070467.txt   242782
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-56243 | Film No.: 21948981
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140
Business Address 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 972-9-9725617
Pontifax Management III G.P. (2011) Ltd. (Filed by) CIK: 0001726335 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13D/A